The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $921,878 in first-year total cost, median $238,752.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMM-K (52)]2
- Cellular and Molecular Immunology - A Study Section[CMIA]1
- Cellular and Molecular Immunology - B Study Section[CMIB]1
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- UNIVERSITY OF MINNESOTA1
- WASHINGTON UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | MYSM1-dependent DNA damage responses in early B cell development1R21AI166259-01A1 | BEDNARSKI, JEFFREY J | WASHINGTON UNIVERSITY, MO | $196,875 | CMIB |
| 2021 | Novel Primary Immunodeficiency Disease Due to IL27RA Deficiency1R21AI156583-01 | FORBES, LISA | BAYLOR COLLEGE OF MEDICINE, TX | $240,750 | CMIA |
| 2020 | Mechanisms of immune dysregulation due to NFKB1 mutation in common variable immunodeficiency1R21AI151486-01 | MAGLIONE, PAUL JOSEPH | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $247,500 | ZRG1 |
| 2020 | A novel autoinflammatory skin disease in a patient with mutations in alpha-T-catenin1R21AI149334-01A1 | BINSTADT, BRYCE | UNIVERSITY OF MINNESOTA, MN | $236,753 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.